Intrinsiqs

Is Bristol-Myers Squibb Company overvalued?

Bristol-Myers Squibb Company (BMY) looks fairly valued — trading about 11% below its fair value.

Fairly valued
Current price $63.43 Fair value $70.12
Price
$63.43
Fair value
$70.12
Current P/E
18.4
Normal P/E
20.3
Market cap
$129.66B
Dividend yield
4.0%
Return on equity
43.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BMY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.